This clinical trial objective is to evaluate the effect of an aerobic physical exercise program on reducing triglycerides, blood pressure, abdominal obesity, altered glucose levels, and the increase in HDL in college-level students at the University of Colima. It will try to answer whether aerobic physical exercise reduces metabolic disorders (altered blood pressure and glucose levels, abdominal obesity, and increased HDL). A simple randomized clinical trial will be conducted with a sample of 48 voluntary students from the University of Colima, divided into two groups of 24 people (Control group -A-, will perform aerobic physical exercise, which will be walking at 57% to 76% of HRmax; and Experimental Group -B-, will undergo an aerobic physical exercise (APE) program involving jogging, swimming, and static cycling, with a progressive intensity, which will start at 57%-63% of the maximum heart rate (HRmax) in the first 4 weeks of the study, and will increase to 64% -76% in the final four weeks, fulfilling the principle of progressive overload).
Researchers will compare the results of both groups to confirm the effectiveness of the planned aerobic physical exercise in reducing these risks.
University of Colima students linked to the central campus.
Students aged between 18 and 25 years old.
Authorization to participate in the project with a signed informed consent.
Suffer from at least one of the parameters of metabolic disorders or cardiovascular risk (Hyperglycemia, decreased DHL, elevated triglycerides, abdominal obesity or hypertension) following the clinical assessment (Considering the criteria established by the ADA and ATPIII).
Motor limitations that may hinder the performance of physical exercise.
Pregnancy or lactation.
High Vigorous Physical Activity Level according to the IPA-Q.
To be currently under pharmacological treatment to manage altered metabolic levels.
Universidad de Colima
Lead sponsor
Pedro Julián Flores Moreno
Collaborator
Nelson Enrique Ramos Cuevas
Collaborator